Current topics in vascular biology: An update for the 21st century;Temas actuales en biología vascular: Puesta al día para el siglo XXI

Revista Espanola de Cardiologia

Volumn 54, Issue 5, 2001, Pages 635-642

  Patterson, C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angiogenesis; Angiogenic gene therapy; Atherosclerosis; Oxidative stress; Vascular biology

Indexed keywords

ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DISEASE MARKER; GENE THERAPY; HUMAN; MEDICAL DECISION MAKING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; VASCULAR DISEASE;

EID: 0038976150     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76366-x     Document Type: Review

References (70)

1. Response to injury and atherogenesis
2. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques in characterized by an inflammatory process irrespective of the dominant plaque morphology
3. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling
4. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
5. An essential role for free radicals and derived species in signal transduction
6. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
7. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
8. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
9. Vitamin E supplementation and cardiovascular events in high-risk patients
10. The oxidative paradox: Another piece of the puzzle
11. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
12. Hypercholesterolemia increases endothelial superoxide anion production
13. 2 for platelet-derived growth factor signal transduction
14. phox may participate in forming this oxidase in vitro and in vivo
15. Differential effects of α-and γ-tocopherol on LDL oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis
16. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
17. Cell transformation by the superoxide-generating oxidase Moxl
18. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
19. - in vascular smooth muscle cells
20. Low density lipoprotein oxidation and its pathobiological significance
21. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal
22. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells
23. IPF2alpha-I: An index of lipid peroxidation in humans
24. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
25. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
26. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
27. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
28. 165 as sole therapy for myocardial ischemia
29. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: Moving on down the road
30. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
31. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - Angiogenesis and angioma formation
32. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
33. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
34. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results
35. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
36. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
37. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease
38. Endarteritis and arteritis
39. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals
40. Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys
41. Intimal neovascularization in human coronary atherosclerosis: Its origin and pathophysiological significance
42. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries
43. Angiogenesis in human coronary atherosclerotic plaques
44. Hemorrhagic and microvascular phenomena within the arterial wall
45. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions
46. Gene targeting and gene transfer studies of the plasminogen/plasmin system: Implications in thrombosis, hemostasis, neointima formation, and atherosclerosis
47. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques
48. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content
49. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
50. Induction of vascular endothelial growth factor in balloon-injured baboon arteries
51. Homocysteine theory of atherosclerosis
52. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
53. Homocysteinemia: Vascular injury and arterial thrombosis
54. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
55. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probably benefits of increasing folic acid intakes
56. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
57. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
58. The relation between acute infectious diseases and arterial lesions
59. Virus-induced atherosclerosis
60. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis
61. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection
62. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of acute myocardial infarction
63. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: The ROXIS pilot study
64. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study
65. Cytokines regulate genes involved in atherogenesis
66. Changing concepts of atherogenesis
67. Plasma concentrations of soluble intracellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy young men
68. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
69. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
70. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women